心肺运动试验评估转甲状腺素蛋白淀粉样变性
本研究纳入506例转甲状腺素蛋白淀粉样变性患者,通过心肺运动试验发现限制性功能损害普遍,不同表型模式各异,且峰值摄氧量与峰值收缩压为独立预后预测因子。
要点
- ATTR淀粉样变性患者功能受损常见,不同表型模式不同
- 变时性功能不全与运动振荡通气普遍且高于其他心衰病因
- 峰值摄氧量与峰值收缩压是独立预后预测因子
核心结论
- ATTR淀粉样变性患者功能损害模式因表型而异,心肺运动试验可能有助于评估功能损害和预测预后。
研究设计与样本
- 单中心研究,2019年5月至2022年9月纳入506例完成心肺运动试验的ATTR淀粉样变性患者,平均随访22.4(11.6)个月。
主要发现
- ATTR-CM和ATTR-mixed表型的峰值摄氧量均值(SD)分别为14.5(4.3)和15.7(6.2)mL/kg/min。
- ATTR-CM的通气效率/二氧化碳排出斜率均值(SD)为38.1(8.6),为最高。
- 变时性功能不全和运动振荡通气在所有表型中普遍存在且程度更重。
- 心脏磁共振淀粉样负荷加重与多项心肺运动试验参数下降相关。
关键数值与推荐
- 排除心肺运动试验绝对禁忌或不参与者,最终纳入506例。
- 平均年龄73.5(10.2)岁,男性457例(90.3%)。
临床怎么用
- 心肺运动试验可用于ATTR淀粉样变性患者功能损害的模式识别和预后评估。
局限性
- 单中心研究,随访时间较短,结果需前瞻性研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Cardiopulmonary exercise testing (CPET) has an established role in the assessment of patients with heart failure. However, data are lacking in patients with transthyretin (ATTR) amyloidosis. OBJECTIVE: To use CPET to characterize the spectrum of functional phenotypes in patients with ATTR amyloidosis and assess their association with the cardiac amyloid burden as well as the association between CPET parameters and prognosis. DESIGN, SETTING AND PARTICIPANTS: This single-center study evaluated patients diagnosed with ATTR amyloidosis from May 2019 to September 2022 who underwent CPET at the National Amyloidosis Centre. Of 1045 patients approached, 506 were included and completed the study. Patients were excluded if they had an absolute contraindication to CPET or declined participation. The mean (SD) follow-up period was 22.4 (11.6) months. MAIN OUTCOMES AND MEASURES: Comparison of CPET parameters across disease phenotypes (ATTR with cardiomyopathy [ATTR-CM], polyneuropathy, or both [ATTR-mixed]), differences in CPET parameters based on degree of amyloid infiltration (as measured by cardiovascular magnetic resonance [CMR] with extracellular volume mapping), and association between CPET parameters and prognosis. RESULTS: Among the 506 patients with ATTR amyloidosis included in this study, the mean (SD) age was 73.5 (10.2) years, and 457 participants (90.3%) were male. Impairment in functional capacity was highly prevalent. Functional impairment in ATTR-CM and ATTR-mixed phenotypes (peak mean [SD] oxygen consumption [VO2], 14.5 [4.3] mL/kg/min and 15.7 [6.2] mL/kg/min, respectively) was observed alongside impairment in the oxygen pulse, with ventilatory efficiency highest in ATTR-CM (mean [SD] ventilatory efficiency/volume of carbon dioxide expired slope, 38.1 [8.6]). Chronotropic incompetence and exercise oscillatory ventilation (EOV) were highly prevalent across all phenotypes, with both the prevalence and severity being higher than in heart failure from different etiologies. Worsening of amyloid burden on CMR was associated with decline in multiple CPET parameters, although chronotropic response and EOV remained abnormal irrespective of amyloid burden. On multivariable Cox regression analysis, peak VO2 and peak systolic blood pressure (SBP) were independently associated with prognosis (peak VO2: hazard ratio, 0.89 [95% CI, 0.81-0.99; P = .03]; peak SBP: hazard ratio, 0.98 [95% CI, 0.97-0.99; P < .001]). CONCLUSIONS AND RELEVANCE: In this study, ATTR amyloidosis was characterized by distinct patterns of functional impairment between all disease phenotypes. A high prevalence of chronotropic incompetence, EOV, and ventilatory inefficiency were characteristic of this population. CPET parameters were associated with amyloid burden by CMR and with peak VO2, and SBP, which have been shown to be independent predictors of mortality. These findings suggest that CPET may be useful in characterizing distinct patterns of functional impairment across the spectrum of amyloid infiltration and predicting outcomes, and potentially offers a more comprehensive method of evaluating functional capacity for future prospective studies.
引用
- Patel RK, Bandera F, Venneri L, et al. Cardiopulmonary Exercise Testing in Evaluating Transthyretin Amyloidosis. JAMA Cardiol. 2024. PMID: 38446436. doi:10.1001/jamacardio.2024.0022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。